Morbidity and Mortality Associated With Balloon Aortic Valvuloplasty

Alkhouli, Mohamad; Zack, Chad J.; Sarraf, Mohammad; Bashir, Riyaz; Nishimura, Rick A.; Eleid, Mackram F.; Nkomo, Vuyisile T.; Sandhu, Gurpreet S.; Gulati, Rajiv; Greason, Kevin L.; Holmes, David R.; Rihal, Charanjit S.

doi:10.1161/circinterventions.116.004481

Cited by 75 publications

(40 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, we speculate that AS patients with AHF may benefit from an early release of the high afterload to the same extent of urgent balloon aortic valvuloplasty in the setting of ASrelated cardiogenic shock. 17 In view of the similar risk of adverse events after balloon aortic valvuloplasty and TAVR, 18 patients with AHF secondary to severe AS may be considered for primary TAVR. Although this may require changes of the diagnostic and treatment pathway, 19 However, the present study was not able to document the validity of TAVR over SAVR in this setting because of the limited number of patients included in this analysis.…”

Section: Commentmentioning

confidence: 99%

Transcatheter and Surgical Aortic Valve Replacement in Patients With Recent Acute Heart Failure

Jalava

Laakso

Virtanen

et al. 2020

The Annals of Thoracic Surgery

View full text Add to dashboard Cite

Section: Commentmentioning

confidence: 99%

Transcatheter and Surgical Aortic Valve Replacement in Patients With Recent Acute Heart Failure

Jalava

Laakso

Virtanen

et al. 2020

The Annals of Thoracic Surgery

View full text Add to dashboard Cite

“…In a more recent National Inpatient Sample study examining percutaneous balloon valvuloplasty between 2004-2013, 84 aortic balloon valvuloplasty vs TAVR was associated with similar rates of in-hospital mortality (2.9% vs 3.5%; P¼.6), clinical stroke (1.6% vs 3.1%; P¼.10), and vascular complications (8.2% vs 10.9%; P¼.14), although aortic balloon valvuloplasty was associated with lower rates of pacemaker implantation (2.9% vs 8.0%; P<.001) and blood transfusion (12.8% vs 22.9%; P<.001).…”

Section: Aortic Balloon Valvuloplastymentioning

confidence: 99%

Management of Patients With Aortic Valve Stenosis

Kanwar

Thaden

Nkomo

2018

Mayo Clinic Proceedings

Self Cite

105

View full text Add to dashboard Cite

With increased life expectancy and aging of the population, aortic stenosis is now one of the most common valvular heart diseases. Early recognition and management of aortic stenosis are of paramount importance because untreated symptomatic severe disease is universally fatal. The advent of transcather aortic valve replacement technologies provides exciting avenues of care to patients with this disease in whom traditional surgical procedures could not be performed or were associated with high risk. This review for clinicians offers an overview of aortic stenosis and updated information on the current status of various treatment strategies. An electronic literature search of PubMed, MEDLINE, EMBASE, and Scopus was performed from conception July 1, 2016, through November 30, 2017, using the terms aortic stenosis, aortic valve replacement, transcatheter aortic valve replacement (TAVR), transcatheter aortic valve insertion (TAVI), surgical aortic valve replacement, aortic stenosis flow-gradient patterns, low-flow aortic valve stenosis, natural history, stress testing, pathophysiology, bicuspid aortic valve, and congenital aortic valve disease.

show abstract

“…Since the aortic valve annulus typically represents the tightest part of the aortic root, sizing of aortic valve annulus has been regarded as the "gold standard" in transcatheter heart valve (THV) size selection [8,9]. In the TAVR era, balloon aortic valvuloplasty is applied to provide additional information for THV size selection when encountering a borderline annulus [10], or as a bridge to TAVR procedure [11].…”

mentioning

confidence: 99%

Supra‐annular structure assessment for self‐expanding transcatheter heart valve size selection in patients with bicuspid aortic valve

Liu

Zhu

et al. 2018

Cathet Cardio Intervent

View full text Add to dashboard Cite

ObjectivesTo explore assessment of supra‐annular structure for self‐expanding transcatheter heart valve (THV) size selection in patients with bicuspid aortic stenosis (AS).BackgroundAnnulus‐based device selection from CT measurement is the standard sizing strategy for tricuspid aortic valve before transcatheter aortic valve replacement (TAVR). Because of supra‐annular deformity, device selection for bicuspid AS has not been systemically studied.MethodsTwelve patients with bicuspid AS who underwent TAVR with self‐expanding THVs were included in this study. To assess supra‐annular structure, sequential balloon aortic valvuloplasty was performed in every 2 mm increments until waist sign occurred with less than mild regurgitation. Procedural results and 30 day follow‐up outcomes were analyzed.ResultsSeven patients (58.3%) with 18 mm; three patients (25%) with sequential 18 mm, 20 mm; and only two patients (16.7%) with sequential 18 mm, 20 mm, and 22 mm balloon sizing were performed, respectively. According to the results of supra‐annular assessment, a smaller device size (91.7%) was selected in all but one patient compared with annulus based sizing strategy, and the outcomes were satisfactory with 100% procedural success. No mortality and 1 minor stroke were observed at 30 d follow‐up. The percentage of NYHA III/IV decreased from 83.3% (9/12) to 16.7% (2/12). No new permanent pacemaker implantation and no moderate or severe paravalvular leakage were found.ConclusionsA supra‐annular structure based sizing strategy is feasible for TAVR in patients with bicuspid AS.

show abstract

Morbidity and Mortality Associated With Balloon Aortic Valvuloplasty

Cited by 75 publications

References 24 publications

Transcatheter and Surgical Aortic Valve Replacement in Patients With Recent Acute Heart Failure

Transcatheter and Surgical Aortic Valve Replacement in Patients With Recent Acute Heart Failure

Management of Patients With Aortic Valve Stenosis

Supra‐annular structure assessment for self‐expanding transcatheter heart valve size selection in patients with bicuspid aortic valve

Contact Info

Product

Resources

About